View Article

Abstract

Migraine remains the second most common cause of disability worldwide. The history and clinical examination are used to make the diagnosis; imaging is typically not required. Depending on the frequency of headaches and the presence or absence of an aura, migraines can be classified. Whether a patient has episodic or chronic migraines depends on the number of headache days. Both the migraine itself and its onset can be treated. In this review, we take a pragmatic approach to migraines using the most recent data.

Keywords

Migraine headache, Headache,Peppermintoil, Lavenderoil, Eucalyptusoil, Ginger extract, Aloe veragel,Acute (abortive) medications, Prevention

Introduction

One of the most prevalent nervous system disorders is headache disorders, which are typified by recurrent headaches. A few primary headache disorders, including migraine, tension-type headache, and cluster headache, are characterized by a painful and incapacitating headache. [1] Among these, migraine headaches are common, prevalent, incapacitating, and basically curable, but they are still underdiagnosed and undertreated. [2] A common chronic headache disorder, migraine is characterized by recurrent attacks that last four to seventy-two hours, have a pulsating quality, can be moderately or severely intense, are exacerbated by regular physical activity, and are accompanied by nausea, vomiting, photophobia, or phonophobia.

 

 

Fig.no.1.1Migraine Headache

Because of its significant impact on the patient's quality of life (QOL), it has been dubbed the seventh disabler. [4] It is the most common reason why kids and teenagers get headaches. Because migraine affects children and their families and because different phenotypes and potential differential diagnoses make diagnosis and treatment challenging, research on migraine in the pediatric population is crucial.

DRUG USED FOR MANAGEMENT OF MIGRAINE HEADACHE

1. Peppermint oil: Peppermint is used in migraine gels because it offers fast, natural, and multi-action relief. Its cooling, analgesic, muscle-relaxing, anti-inflammatory, and aromatherpeutic properties work together to reduce migraine pain safely and effectively.

Phytoconstituents – Peppermint (Mentha piperita) is rich in bioactive compounds, primarily menthol (35–60%) and menthone (15–32%), which define its aroma and therapeutic properties. Other key constituents include menthyl acetate, 1,8-cineole (eucalyptol), limonene, menthofuran, acids (rosmarinic acid), and flavonoids (hesperidin, luteolin).

2. Lavender oil: Lavender (Lavandula angustifolia) is commonly used in migraine gel because of its analgesic, calming, and anti-inflammatory properties. It helps relieve headache and migraine symptoms through multiple mechanisms.

Phytoconstituents – Lavender contains over 300 active compounds, primarily essential oils, with linalool (24–38%) and linalyl acetate (26–36%) as the dominant therapeutic constituents. These volatile monoterpenes are responsible for its sedative, antioxidant, antimicrobial, and anti-inflammatory properties. Other significant compounds include terpinen-4-ol, lavandulol, camphor, and various phenolic acids.

3. Eucalyptus oil: Eucalyptus (Eucalyptus globulus) is used in migraine gel because of its analgesic, cooling, anti-inflammatory, and vasomodulatory properties, which help reduce headache and migraine symptoms.

Phytoconstituents – Eucalyptus leaves are rich in phytochemicals, primarily dominated by volatile oils, with 1,8-cineole (eucalyptol) being the major compound (40–90%) responsible for its medicinal properties. Key constituents include monoterpenes (α-pinene, limonene), sesquiterpenes, flavonoids (eucalyptin), tannins, and phenolic acids.

      

 

                                         Eucalyptol

4. Ginger extract: Ginger (Zingiber officinale) is increasingly used in topical migraine gels and pastes because it contains potent bioactive compounds that target the physiological trigger of a migraine—specifically inflammation and blood vessel changes—without the systemic side effects of oral medication.

Phytoconstituents – Ginger contains over 400 active compounds, primarily phenolics and terpenes, that provide antioxidant, anti-inflammatory, and antimicrobial properties. The major pungent, bioactive compounds include gingerols, which convert to shogaols during heating/storage, along with paradols, zingerone, and essential oils like zingiberene.

5. Aloe vera gel: Aloe vera is used in migraine gel mainly as a soothing base and anti-inflammatory agent. It enhances both the effectiveness and skin compatibility of the gel.

Phytoconstituents – Aloe vera contains over 110 active phytochemicals, primarily found in the leaf gel and yellow latex, vitamins (A, C, E), enzymes, minerals, lignin, saponins, and salicylic acid. These compounds provide antioxidant, anti-inflammatory, and antimicrobial properties

 

                                  Polysaccharides(Acemannan)

 

                                        Aloe Emodin                                                            Aloesin

SAFETY PROFILE AND SIDE EFFECTS

Migraine treatments are generally divided into acute (abortive) and preventive categories, each with distinct safety considerations. Because many migraine medications work by affecting blood vessels or neurotransmitters like serotonin, their safety profiles often focus on cardiovascular health and neurological side effects.

ACUTE (ABORTIVE) MEDICATION

Acute migraine medications, or abortive treatments, aim to stop headaches in progress and are most effective when taken immediately. First-line options include NSAIDs (ibuprofen, naproxen), acetaminophen, and caffeine combinations (Excedrin). Prescription triptans (sumatriptan, rizatriptan) are highly effective, while newer options include gepants (Ubrelvy, Zavzpret) and ditans.

PREVENTION

Prevent headaches by maintaining a consistent daily routine: sleep 7–9 hours, stay hydrated, eat balanced meals regularly, and manage stress through techniques like yoga or deep breathing. Reduce screen time using the 20-20-20 rule, maintain good posture, limit alcohol and caffeine, and keep a headache diary to identify triggers.

CONCLUSION

The anti-migraine gel represents a significant advancement in localized pain management. By bypassing the gastrointestinal tract, it offers a rapid-onset alternative for patients who suffer from nausea or those who do not respond well to oral medications. Its ability to deliver targeted relief directly to the trigeminal nerve pathways makes it a versatile and essential tool in a comprehensive migraine management toolkit.

REFERENCES

  1. World Health Organization. WHO Fact sheet, 2016, 1-2.
  2. The World Health Organization. A public health perspective on neurological disorders.Neurol Disord Public Healing Challenges, 2006, 41–176.
  3. Gordon-Smith K. et al. Rapid cycling as a characteristic of comorbid migraine and bipolar disorder. J Affect Disord [Online].
  4. Gooriah R. et al. Evidence-based migraine treatments for adults. 2015; Pain Res Treat.
  5. Tarasco V. et al. Northern Italian pediatric migraine epidemiology and clinical characteristics. 2016; 36(6): 510–7 Cephalalgia [Internet].
  6. Research on the pathophysiology and genetic foundation of migraine by Gasparini CF. et al. Curr Genomics
  7. Rogawski MA. Common Pathophysiologic Mechanisms in Epilepsy and Migraine. Arch Neurol, 65(6), 709–14 (2008).
  8. Mallaoglu M. Migraine patients' trigger factors. Journal of Health Psychology, 18(7), 984-94 (2012).
  9. Brett R. et al. Treating a 23-Year-Old with Dietary and Lifestyle Modifications A female patient with migraines. J. Chiropr Med [Online]. 2015; 14(3): 205–11; National University of Health Sciences.
  10. The International Headache Society's Headache Classification Committee. Cephalagia, 2013; 33(9): 629–808. The International Classification of Headache Disorders, Third Edition.
  11. William EM. et al. Nonpharmacologic migraine management guidelines for clinical practice. Can Med Assoc, 159(1), 47–54 (1998).
  12. Tepper ST. et al. 5-HT Mechanisms of Action. Arch Neurol, 2002; 59: 1084–8.
  13. Thorlund K. and others. Triptans' relative effectiveness in treating migraines: a meta-analysis of multiple treatment comparisons. Cephalalgia, 34(4), 258–67 (2014).
  14. Derry S. Moore RA. Adults with acute migraine headaches can take paracetamol (acetaminophen) with or without an antiemetic. Cochrane Database Syst Rev, 30(4), 2013.
  15. Rabbie R. et al. Ibuprofen for adult acute migraine headaches, either with or without an antiemetic. Cochrane Database Syst Rev, 30(4), 2013.
  16. Derry S. et al. Diclofenac for adult acute migraine headaches, either with or without an antiemetic. 20(9): 51; Curr Pain Headache Rep., 2016.
  17. Law S. et al. Naproxen for acute migraine headaches in adults, either with or without an antiemetic. Cochrane Database Syst Rev, 20 (10), 2013.
  18. Talabi S. et al. A randomized clinical trial comparing metoclopramide and sumatriptan for migraine headache treatment. J Res Med Sci, 18(8): 695–8 (2013).

Reference

  1. World Health Organization. WHO Fact sheet, 2016, 1-2.
  2. The World Health Organization. A public health perspective on neurological disorders.Neurol Disord Public Healing Challenges, 2006, 41–176.
  3. Gordon-Smith K. et al. Rapid cycling as a characteristic of comorbid migraine and bipolar disorder. J Affect Disord [Online].
  4. Gooriah R. et al. Evidence-based migraine treatments for adults. 2015; Pain Res Treat.
  5. Tarasco V. et al. Northern Italian pediatric migraine epidemiology and clinical characteristics. 2016; 36(6): 510–7 Cephalalgia [Internet].
  6. Research on the pathophysiology and genetic foundation of migraine by Gasparini CF. et al. Curr Genomics
  7. Rogawski MA. Common Pathophysiologic Mechanisms in Epilepsy and Migraine. Arch Neurol, 65(6), 709–14 (2008).
  8. Mallaoglu M. Migraine patients' trigger factors. Journal of Health Psychology, 18(7), 984-94 (2012).
  9. Brett R. et al. Treating a 23-Year-Old with Dietary and Lifestyle Modifications A female patient with migraines. J. Chiropr Med [Online]. 2015; 14(3): 205–11; National University of Health Sciences.
  10. The International Headache Society's Headache Classification Committee. Cephalagia, 2013; 33(9): 629–808. The International Classification of Headache Disorders, Third Edition.
  11. William EM. et al. Nonpharmacologic migraine management guidelines for clinical practice. Can Med Assoc, 159(1), 47–54 (1998).
  12. Tepper ST. et al. 5-HT Mechanisms of Action. Arch Neurol, 2002; 59: 1084–8.
  13. Thorlund K. and others. Triptans' relative effectiveness in treating migraines: a meta-analysis of multiple treatment comparisons. Cephalalgia, 34(4), 258–67 (2014).
  14. Derry S. Moore RA. Adults with acute migraine headaches can take paracetamol (acetaminophen) with or without an antiemetic. Cochrane Database Syst Rev, 30(4), 2013.
  15. Rabbie R. et al. Ibuprofen for adult acute migraine headaches, either with or without an antiemetic. Cochrane Database Syst Rev, 30(4), 2013.
  16. Derry S. et al. Diclofenac for adult acute migraine headaches, either with or without an antiemetic. 20(9): 51; Curr Pain Headache Rep., 2016.
  17. Law S. et al. Naproxen for acute migraine headaches in adults, either with or without an antiemetic. Cochrane Database Syst Rev, 20 (10), 2013.
  18. Talabi S. et al. A randomized clinical trial comparing metoclopramide and sumatriptan for migraine headache treatment. J Res Med Sci, 18(8): 695–8 (2013).

Photo
Nutan Sahu
Corresponding author

Rungta Institute of Pharmaceutical Sciences, Kohka Kurud, Bhilai

Photo
Himani Netam
Co-author

Rungta Institute of Pharmaceutical Sciences, Kohka Kurud, Bhilai

Photo
V. Ramya Sri
Co-author

Rungta Institute of Pharmaceutical Sciences and Research, Kohka Kurud, Bhilai, Chhattisgarh, India

Photo
Nidhi Soni
Co-author

Rungta Institute of Pharmaceutical Sciences, Kohka Kurud, Bhilai

Photo
Nishika Tamrakar
Co-author

Rungta Institute of Pharmaceutical Sciences and Research, Kohka Kurud, Bhilai, Chhattisgarh, India

Photo
Hemlata Dewangan
Co-author

Rungta Institute of Pharmaceutical Sciences and Research, Kohka Kurud, Bhilai, Chhattisgarh, India

Photo
Suchita Wamankar
Co-author

Rungta Institute of Pharmaceutical Sciences, Kohka Kurud, Bhilai

Photo
Dr. Gyanesh Kumar Sahu
Co-author

Rungta Institute of Pharmaceutical Sciences and Research, Kohka Kurud, Bhilai, Chhattisgarh, India

Himani Netam, V. Ramya Sri, Nidhi Soni, Nishika Tamrakar, Hemlata Dewangan, Nutan Sahu, Suchita Wamankar, Dr. Gyanesh Kumar Sahu, Formulation and Evaluation of Herbal Headache Relief Gel, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 4, 3492-3496. https://doi.org/10.5281/zenodo.19681191

More related articles
Targeted Therapies in Blood Cancer...
Sanchit Armal, Radheshyam Azade, Om Avhale, Prashant Ingle, Dr. S...
Metal Nanoparticles in the Management of Bacterial...
Dr. Jisha Mohanan, Ashik T N, Aparna E, Muhammed Danish Haneefa, ...
Review On Study the Sop for Handling of Equipments...
Dnyaneshwari Wankhade , Hritika Bayaskar , Janhavi keche, Kalyani...
Related Articles
SPLENOPROTECTIVE EFFECT OF KUDZU ROOT EXTRACT IN ANILINE INDUCED SPLEEN TOXICITY...
Aman Upaganlawar, Sumitkumar Sharma, Aakif Bagwan, Mangesh Tatar, Chandrashekar Upasani, ...
Design, Develop and Validate a Tool for Assessing Drug Related Problems in Cance...
Deepanmita Wakalwar, Edward Williams, Narendra Parihar, Ankit Agarwal, Mahendra Singh Rathore, ...
Targeted Therapies in Blood Cancer...
Sanchit Armal, Radheshyam Azade, Om Avhale, Prashant Ingle, Dr. Shivshankar Mhaske, ...
More related articles
Targeted Therapies in Blood Cancer...
Sanchit Armal, Radheshyam Azade, Om Avhale, Prashant Ingle, Dr. Shivshankar Mhaske, ...
Metal Nanoparticles in the Management of Bacterial Biofilms: Mechanisms and Biom...
Dr. Jisha Mohanan, Ashik T N, Aparna E, Muhammed Danish Haneefa, ...
Review On Study the Sop for Handling of Equipments Used in Formulation and Evalu...
Dnyaneshwari Wankhade , Hritika Bayaskar , Janhavi keche, Kalyani Ranotkar , Kunal Takarkhade, ...
Targeted Therapies in Blood Cancer...
Sanchit Armal, Radheshyam Azade, Om Avhale, Prashant Ingle, Dr. Shivshankar Mhaske, ...
Metal Nanoparticles in the Management of Bacterial Biofilms: Mechanisms and Biom...
Dr. Jisha Mohanan, Ashik T N, Aparna E, Muhammed Danish Haneefa, ...
Review On Study the Sop for Handling of Equipments Used in Formulation and Evalu...
Dnyaneshwari Wankhade , Hritika Bayaskar , Janhavi keche, Kalyani Ranotkar , Kunal Takarkhade, ...